Advertisement

Topics

Integrating Novel Targets and Precision Medicine Into Prostate Cancer Care—Part 1: The Non-Androgen–Targetable Pathways in Castration-Resistant Prostate Cancer

20:00 EDT 12 Mar 2019 | Cancer Networks

Here, we review the current use and future direction of novel therapeutic targets in the treatment of castration-resistant prostate cancer.

Original Article: Integrating Novel Targets and Precision Medicine Into Prostate Cancer Care—Part 1: The Non-Androgen–Targetable Pathways in Castration-Resistant Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Integrating Novel Targets and Precision Medicine Into Prostate Cancer Care—Part 1: The Non-Androgen–Targetable Pathways in Castration-Resistant Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement